Table 6.
cTnI(±s ng/L) | CysC (±s mg/L) | |||||
---|---|---|---|---|---|---|
Pre-treatment | 24 hrs after treatment | 48 hrs after treatment | Pretreatment | 24 hrs after treatment | 48 hrs after treatment | |
Normal (n=8) | 98.45±84.76 | 0.84±0.08 | ||||
Group A (n=11) | 423.19±240.53* | 218.34±76.38 | 106.12±51.41Δ# | 3.87±0.69* | 2.06±0.28 | 1.17±0.42Δ# |
Group B (n=12) | 407.38±263.27* | 237.42±85.36 | 125.16±53.25# | 3.56±0.35* | 2.38±0.42 | 1.45±0.44# |
Group C (n=12) | 416.15±252.23* | 314.81±90.32 | 184.57±64.37 | 3.71±0.71* | 2.87±0.54 | 1.98±0.61 |
Notes: cTnI treatment factor main effects, F=43.1, P<0.01, time factor main effect, F=30.26, P<0.01, interaction between the two, F=14.41, P<0.01; CysC treatment factor main effects, F=7.16, P<0.01, time factor main effect, F=173.77, P<0.01, interaction between the two, F=5.81, P<0.01; *P<0.01 vs normal, ΔP<0.05 vs group B, #P<0.01 vs group C.
Abbreviations: cTnI, cardiac troponinI; CysC, cystatin C.